Providers win approximately 80% of Federal IDR disputes.

That is not a projection. That is documented CMS data from hundreds of thousands of disputes resolved through the No Surprises Act’s independent arbitration process since 2022.

Most independent practices do not know this process exists. Or they know it exists and assume it’s too complicated to bother with. Or they filed once, found the process confusing, and walked away.

That gap — between what the law gives you and what you’re actually using — is one of the most significant recoverable revenue opportunities sitting in your AR right now.

Here’s where the process stands, what’s shifting, and what to do about it.

The Process Works. Use It.

The Federal IDR process is fully operational. Disputes are being filed, arbitrators are deciding, and payment determinations are being issued and honored. Providers are selecting offers at an 80% clip.

If you have out-of-network claims where the payer’s initial payment feels low — and you’re just accepting it — you’re not declining a long shot. You’re declining an 80% win.

The only real question is whether the dollar amount on the claim justifies the $115 administrative filing fee and the staff time to submit.

What’s Actually Changing: The QPA Litigation

The part that is not settled is the Qualifying Payment Amount — the payer-established benchmark that arbitrators use as their starting reference point.

The Texas Medical Association has run a series of legal challenges (TMA I through TMA IV) targeting the QPA calculation methodology. The core argument: federal regulations allow payers to deflate the QPA below actual median in-network rates by including “ghost rates” — rates for services providers never intended to offer — and other methodological choices that skew the benchmark in the payer’s favor.

In 2023, a federal district court sided with providers and vacated key QPA calculation provisions. The government appealed. The Fifth Circuit initially upheld the government’s methodology. Providers then won en banc review — meaning the full Fifth Circuit, not just a three-judge panel, will rehear the case.

As of today, that en banc decision has not been issued.

CMS has extended enforcement discretion on QPA calculations while waiting for the court. The QPA methodology currently in use may change depending on how the Fifth Circuit rules.

The Statutory Factors: Your Real Leverage

The arbitrator selects one of two submitted offers — yours or the payer’s. The goal is not to submit the highest number you can defend. It is to submit the number most likely to be selected over the payer’s number.

The statutory factors are what move the arbitrator above the QPA:

• Provider training, experience, and quality outcomes — document what makes your practice’s services worth more than the payer’s baseline
• Market rate comparables — what are similar providers in your market actually being paid?
• Complexity of the case — acuity, comorbidities, time, and clinical decision-making all count
• Demonstration of good faith — show you participated in open negotiation and the payer did not respond reasonably

Every IDR submission should include a statutory factor argument. Every one. The practices winning at 80% are not winning on the QPA alone. They’re winning because they built a case.

Your Action Item This Week

That’s your IDR opportunity list. Start there.

The open negotiation period — the 30-day window before you can file IDR — starts from the date of the initial payment or denial. If you have claims where that window has already passed, you can still file. You have up to 4 business days after the end of the open negotiation period to initiate IDR.

For the full process walkthrough, eligibility criteria, batching mechanics, and 90-day implementation plan: Federal IDR Playbook →